Abstract
Gastroesophageal Reflux Disease (GERD) is one of the upper gastrointestinal tract diseases whose prevalence continues to increase globally, including in Indonesia, with the global prevalence of 8% to 33% according to World Gastroenterology Organization. Management of GERD involves two main approaches, namely lifestyle modification and pharmacologic therapy. However, the effectiveness and response of patients to drugs vary, so the selection of treatment regimens needs to be tailored to the clinical condition, patient tolerability, and applicable guidelines. This research method uses a systematic literature review approach to examine the medication patterns of GERD towards patients within a few hospitals. Literature was searched using Google Scholar with the inclusion criteria of relevant articles published in the range of 2015-2025, resulting in one main article and five supporting articles. The results showed that the pattern of GERD treatment in hospitals is generally dominated by the use of Proton Pump Inhibitors (PPIs), either as a single therapy or in combination with antacids.
References
Fitriani, D., Sulastri, R., & Maulana, R. (2023). Treatment Pattern of GERD in the Outpatient Installation of Hospital X in Bandung. Indonesian Clinical Pharmacy Journal, 9(2), 101-108.
Freedberg, D. E., Kim, L. S., & Yang, Y. X. (2021). The risks and benefits of long-term use of proton pump inhibitors: expert review and best practice advice from the American Gastroenterological Association. Gastroenterology, 160(4), 1281-1293.
Islam, M. A., Rahman, S., & Hasan, M. R. (2021). Comparative Study of GERD Treatment Patterns in Tertiary Hospitals. International Journal of Medical Research, 5(1), 45-52.
Katz, P. O., Gerson, L. B., & Vela, M. F. (2022). Guidelines for the diagnosis and management of gastroesophageal reflux disease. The American Journal of Gastroenterology, 117(1), 27-55.
Lee, J. H., Kim, J. H., & Park, S. J. (2023). Proton Pump Inhibitor Use and Clinical Outcomes in Gastroesophageal Reflux Disease: A Multicenter Cohort Study. Journal of Gastroenterology and Hepatology, 38(5), 876-884.
Nurfadillah, N., Yuliana, L., & Harahap, A. (2022). Effectiveness of Omeprazole and Ranitidine in the Management of GERD. Journal of Medika Health Sciences, 13(1), 55-63.
Sari, P., & Nugroho, A. (2019). PPI use based on GERD severity. Journal of Pharmacy and Health, 6(1), 35-41.
Tran, T. H., Nguyen, P. T., & Le, Q. T. (2022). Rational Use of Proton Pump Inhibitors in GERD Patients: Evaluation of Prescribing Patterns in Vietnam. International Journal of Clinical Pharmacy, 44(6), 1491-1499.
Vaezi, M. F., Yang, Y. X., & Howden, C. W. (2022). Complications of proton pump inhibitor therapy. Gastroenterology, 162(4), 1232-1245.
Wicaksono, D., Santosa, E., & Lestari, N. D. (2020). Evaluation of the Rationality of PPI Use in GERD Patients in Public Hospitals. Journal of Health Science and Technology, 8(2), 120-127.
Sinuraya, R. K., Zairina, E., & Zairin, M. (2018). The level of treatment compliance of hypertension patients in first-level health facilities in Bandung City. Indonesian Clinical Pharmacy Journal, 7(2), 84-91.
This work is licensed under a Creative Commons Attribution 4.0 International License.
Copyright (c) 2025 Anggi Isnaini, Vian Saltiel Harefa, Dafni Aisyah Fariby, Najwa Adella Feriska, Falesya Jovanka Athallah, Anisa Puja Ningrum, Shabina Putri Alliya, Daniah Atikah, Wafa